Literature DB >> 2549753

In vitro effects of ketoconazole on corticotrope cell morphology and ACTH secretion of two pituitary adenomas removed from patients with Nelson's syndrome.

L Jimenez Reina1, A Leal-Cerro, J Garcia, P P Garcia-Luna, R Astorga, G Bernal.   

Abstract

The direct effects of ketoconazole on the secretion of ACTH by human pituitary adenoma cells from 2 patient with Nelson's syndrome were studied in vitro. Stereologically quantified, intracellular changes affect the surface density of the endoplasmic reticulum (it decreased by 73%), the volume density of the secretion granules (it decreased by 49%), and the volume density of lysosomes (it decreased by 67%). The hormone released in the culture medium decreased depending on the doses of ketoconazole used; 10 mumol/l decreased ACTH levels by 31%. These data show that ketoconazole induce marked changes on corticotrope morphology and ACTH secretion in pituitary cells obtained from patients with Nelson's syndrome.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2549753     DOI: 10.1530/acta.0.1210185

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  6 in total

Review 1.  The Treatment of Cushing's Disease.

Authors:  Rosario Pivonello; Monica De Leo; Alessia Cozzolino; Annamaria Colao
Journal:  Endocr Rev       Date:  2015-06-11       Impact factor: 19.871

Review 2.  Medical therapy of Cushing's disease.

Authors:  Lynnette K Nieman
Journal:  Pituitary       Date:  2002       Impact factor: 4.107

3.  Spontaneous remission of Cushing's disease after disappearance of a microadenoma attached to the pituitary stalk.

Authors:  Analía B Pignatta; Adriana G Díaz; Reynaldo M Gómez; Oscar D Bruno
Journal:  Pituitary       Date:  2004       Impact factor: 4.107

Review 4.  Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement.

Authors:  B M K Biller; A B Grossman; P M Stewart; S Melmed; X Bertagna; J Bertherat; M Buchfelder; A Colao; A R Hermus; L J Hofland; A Klibanski; A Lacroix; J R Lindsay; J Newell-Price; L K Nieman; S Petersenn; N Sonino; G K Stalla; B Swearingen; M L Vance; J A H Wass; M Boscaro
Journal:  J Clin Endocrinol Metab       Date:  2008-04-15       Impact factor: 5.958

Review 5.  Therapeutic Strategies for the Treatment of Severe Cushing's Syndrome.

Authors:  Krystallenia I Alexandraki; Ashley B Grossman
Journal:  Drugs       Date:  2016-03       Impact factor: 9.546

6.  Management Strategies for Aggressive Cushing's Syndrome: From Macroadenomas to Ectopics.

Authors:  Carlotta Pozza; Chiara Graziadio; Elisa Giannetta; Andrea Lenzi; Andrea M Isidori
Journal:  J Oncol       Date:  2012-08-09       Impact factor: 4.375

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.